Search results
Results From The WOW.Com Content Network
t. e. The Drug Price Competition and Patent Term Restoration Act (Public Law 98-417), informally known as the Hatch-Waxman Act, is a 1984 United States federal law that established the modern system of generic drug regulation in the United States. The Act's two main goals are to facilitate entry of generic drugs into the market and to ...
The Anti-Drug Abuse Act of 1988 ( Pub. L. 100–690, 102 Stat. 4181, enacted November 18, 1988, H.R. 5210) is a major law of the War on Drugs passed by the U.S. Congress which did several significant things: Created the policy goal of a drug-free America; Established the Office of National Drug Control Policy; [ 2] and.
An Abbreviated New Drug Application ( ANDA) is an application for a U.S. generic drug approval for an existing licensed medication or approved drug . The ANDA is submitted to FDA's Center for Drug Evaluation and Research, Office of Generic Drugs, which provides for the review and ultimate approval of a generic drug product.
Although the average price of a generic prescription covered by Medicare Part D plans is $17 and has fallen since 2009, according to the Congressional Budget Office, 12% of Medicare beneficiaries ...
A generic drug (or simply generic) is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active chemical substance is the same, the medical profile of generics is equivalent in ...
Signed into law by President George H. W. Bush on October 29, 1992. The Prescription Drug User Fee Act ( PDUFA) was a law passed by the United States Congress in 1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process. The Act provided that the FDA was entitled to ...
September 13 – Generics Act of 1988 (Republic Act No. 6675) was signed by President Aquino in order to require and ensure the production of an adequate supply, distribution, use and acceptance of drugs and medicines identified by their generic name.
The Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 ( S. 622; Pub. L. 113–14 (text) (PDF)) is a bill that was introduced into the United States Senate during the 113th United States Congress. The bill would authorize the collection of fees by the Food and Drug Administration for use to fund activities related to the ...